» Articles » PMID: 35322451

Molecular Biomarker Research in Periodontology: A Roadmap for Translation of Science to Clinical Assay Validation

Overview
Date 2022 Mar 24
PMID 35322451
Authors
Affiliations
Soon will be listed here.
Abstract

The number of studies that aims to apply host- or microbe-derived biochemical biomarkers to periodontal disease diagnosis has increased significantly during the last three decades. The biochemical markers can reflect the presence, severity, and activity of periodontal diseases; however, heterogeneities in applied laboratory methods, data presentation, statistical analysis, and data interpretation prevent the translation of candidate host- or microbe-derived biochemical biomarkers to clinical assay validation. Here, we propose a roadmap for making the research outcomes comparable and re-analysable with the ultimate goal of translating research to clinical practice. This roadmap presents reporting recommendations for host- or microbe-derived biochemical biomarker studies in periodontology. We aim to make essential elements of the research work (including diagnostic criteria, clinical endpoint definitions, participant recruitment criteria, sample collection and storage techniques, biochemical and microbiological detection methods, and applied statistical analysis) visible and comparable.

Citing Articles

Meteorin-like levels of oral fluids in periodontal health and diseases: a comparative cross-sectional study.

Saglam E, Toraman A, Savran L, Saglam M, Koseoglu S Clin Oral Investig. 2025; 29(2):137.

PMID: 39964474 PMC: 11836087. DOI: 10.1007/s00784-025-06222-7.


Diagnostic Accuracy of Novel Protein Biomarkers in Saliva to Detect Periodontitis Using Untargeted 'SWATH' Mass Spectrometry.

Blanco-Pintos T, Regueira-Iglesias A, Relvas M, Alonso-Sampedro M, Bravo S, Balsa-Castro C J Clin Periodontol. 2024; 52(2):199-214.

PMID: 39730307 PMC: 11743018. DOI: 10.1111/jcpe.14103.


Oral biofluid levels of Activin-A and interleukin-1beta in stage III periodontitis.

Ozden C, Afacan B, Ilhan H, Kose T, Emingil G Clin Oral Investig. 2024; 29(1):7.

PMID: 39656274 DOI: 10.1007/s00784-024-06088-1.


"Outcome of non-surgical periodontal treatment on Gal-1 and Gal-3 GCF levels in periodontitis patients: a case-control study".

Abdel Fattah Tarrad N, Shaker O, Elbanna R, Abdelkawy M Clin Oral Investig. 2024; 28(6):309.

PMID: 38743248 PMC: 11093871. DOI: 10.1007/s00784-024-05688-1.


Salivary Th17 cytokine, human β-defensin 1-3, and salivary scavenger and agglutinin levels in Crohn's disease.

Gursoy U, Gursoy M, Loimaranta V, Rautava J Clin Oral Investig. 2024; 28(1):108.

PMID: 38246944 PMC: 10800300. DOI: 10.1007/s00784-024-05509-5.


References
1.
Sedgwick P . Bias in observational study designs: case-control studies. BMJ. 2015; 350:h560. DOI: 10.1136/bmj.h560. View

2.
Schaefer A . Genetics of periodontitis: Discovery, biology, and clinical impact. Periodontol 2000. 2018; 78(1):162-173. DOI: 10.1111/prd.12232. View

3.
Claffey N, Nylund K, Kiger R, Garrett S, Egelberg J . Diagnostic predictability of scores of plaque, bleeding, suppuration and probing depth for probing attachment loss. 3 1/2 years of observation following initial periodontal therapy. J Clin Periodontol. 1990; 17(2):108-14. DOI: 10.1111/j.1600-051x.1990.tb01071.x. View

4.
Arias-Bujanda N, Regueira-Iglesias A, Balsa-Castro C, Nibali L, Donos N, Tomas I . Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis: A systematic review and meta-analysis. J Clin Periodontol. 2019; 47(1):2-18. DOI: 10.1111/jcpe.13202. View

5.
Gursoy U, Gursoy M, Kononen E . Biomarkers and Periodontal Regenerative Approaches. Dent Clin North Am. 2021; 66(1):157-167. DOI: 10.1016/j.cden.2021.06.006. View